Exploring pelvic pain in transgender individuals using testosterone therapy
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
This study looks at how chronic pelvic pain affects the lives of transgender men who are on testosterone therapy and what challenges they face in getting healthcare for it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Saint-Martin-d'Hères) |
| Trial ID | NCT06487754 on ClinicalTrials.gov |
What this trial studies
This observational qualitative study aims to describe the characteristics of chronic pelvic pain experienced by transgender individuals undergoing testosterone therapy and its impact on their quality of life. The study will involve semi-structured interviews with 10 to 15 transmasculine participants who have experienced pelvic pain for at least six months, which has changed since starting testosterone. The research will also investigate the barriers and facilitators to seeking healthcare for this condition, utilizing qualitative analysis methods for data interpretation.
Who should consider this trial
Good fit: Ideal candidates for this study are transmasculine individuals who are currently on testosterone therapy and have experienced pelvic pain that has developed or changed since starting treatment.
Not a fit: Patients who are not undergoing testosterone therapy or who do not experience pelvic pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of pelvic pain in transgender individuals, enhancing their quality of life.
How similar studies have performed: While there is limited research specifically on pelvic pain in transgender individuals using testosterone, qualitative studies in similar populations have shown promise in understanding health-related issues.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being a trans masculine individual * Taking a gender affirming hormonal therapy (GAHT) * living close to Grenoble * having pelvic pain that appeared or were modified after taking GAHT Exclusion Criteria: * Subject under guardianship or subject deprived of liberty Refusal of voice recording
Where this trial is running
Saint-Martin-d'Hères
- Uga — Saint-Martin-d'Hères, France (Recruiting)
Study contacts
- Study coordinator: SaraEve Graham Longsworth, MSc
- Phone: +33646820783
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.